![Ori Kalid](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ori Kalid
Directeur Technique/Scientifique/R&D chez
PROTALIX BIOTHERAPEUTICS, INC.
Profil
Ori Kalid was the founder of Pi Therapeutics Ltd., founded in 2015, and held the title of Chief Executive Officer.
Dr. Kalid is currently Vice President-Research & Development at Protalix Biotherapeutics, Inc. since 2024.
Formerly, Dr. Kalid was Chief Executive Officer at Pi Therapeutics Ltd. Dr. Kalid completed undergraduate, graduate, and doctorate degrees at Tel-Aviv University.
Postes actifs de Ori Kalid
| Sociétés | Poste | Début |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/06/2024 |
Anciens postes connus de Ori Kalid
| Sociétés | Poste | Fin |
|---|---|---|
Pi Therapeutics Ltd.
 Pi Therapeutics Ltd. BiotechnologyHealth Technology Develops a proprietary cancer drug | Directeur Général | - |
Pi Therapeutics Ltd.
Pi Therapeutics Ltd. BiotechnologyHealth Technology Develops a proprietary cancer drug | Directeur Général | - |
Formation de Ori Kalid
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protalix Biotherapeutics, Inc.
 Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins | Health Technology |
Pi Therapeutics Ltd.
Pi Therapeutics Ltd. BiotechnologyHealth Technology Develops a proprietary cancer drug | Health Technology |
